1. The applicant institution must be a non-profit, charitable institution, such as a university, hospital, or research organization. Applications are accepted from institutions worldwide.

  2. The applicant who wishes to take on the Principal Investigator position must have a faculty appointment at the institution.  For this, we request that the applicant's university or institution (particularly the Grants and Contracts personnel) send us a statement confirming that the applicant is or is not able to apply as a Principal Investigator from his/her institution.

  3. There can be only one Principal Investigator for each proposal.


  • Funding can be requested for up to two years, but grants generally are funded only one year at a time. If a PI wishes to seek continuation funding, funding for a second year is based upon a satisfactory Progress Report (see “Continuation Funding” below), which will undergo review from the BMRP director, and in some cases a peer review.
  • Budgets should be appropriate for the project’s scope of work and absolute needs. All necessary costs for conduct of the study can be budgeted, including items such as personnel, supplies, equipment, publications costs and travel. There is no fixed upper or lower limit of funding, but keep in mind that we are a small foundation with limited funds. To see the range of funding we have awarded, see "Grant Funding Awarded Annually" in the "Program Statistics" section of our website.
  • Travel costs to attend the Annual BMRP Investigator Meeting must be budgeted (see “Meetings”). Funds awarded for travel and related costs to attend the BMRP Investigator Meeting are restricted and cannot be used for any other purpose without prior BMRP approval. The Principal Investigator is expected to attend the two day annual meeting.  Travel to attend other scientific meetings is not allowed. Other travel that is necessary to conduct the study must be fully justified and itemized separately from the BMRP Investigator Meeting costs. Only economy airfare is allowable.
  • The maximum indirect costs/overhead that can be requested is 10% based upon total direct costs. Once a grant is awarded, funds cannot be transferred out of direct costs to cover indirect or overhead costs even if less than the maximum allowed indirect costs were requested.
  • Except as indicated above, all other rebudgeting to cover the necessary and reasonable costs of the research project is allowable without prior BMRP approval.
  • If you have a particular project and budget in mind and wish clarification regarding whether it is appropriate, please contact us.


Continuation Funding / Progress Report To BMRP

  • BMRP grants aim to facilitate innovative IBD research while enabling the Principal Investigator to obtain long-term funding from other agencies. The crucial experiments that are necessary to validate the hypothesis should be completed as early as possible in Year 1. It is expected that grantees apply for other long-term funding during Year 1 if the hypothesis of the award is confirmed by preliminary data. Continuation support is possible if grantee can document the need for a second year from the BMRP in order to strengthen the chances for other funding.

    IMPORTANT NOTE: Starting September 1, 2014, the BMRP will require a PROGRESS REPORT within Year 1 of funding. This will replace the formerly implemented Continuation Application process, and will be completed whether or not you wish to seek funding for a second year.  Progress Report instructions and forms will be provided on Proposal Central.

  • The Annual Progress Report and the Annual Financial Expenditure Report are due 2 months before the grant end date.

  • The Final Reports (Final Progress Report and Final Financial Report) are due no later than 90 days after the grant end date.

  • Submission of the Annual Progress Report and Annual Financial Expenditure Report is required to receive the 4th quarterly payment of your grant’s funding for the current award period. The 4th quarterly payment will be withheld until the Progress Report and Financial Expenditure Report have been received and approved on Proposal Central.

  • Please be aware that the Progress Report may require revisions. This will be at the director’s discretion and will allow submission after the target deadline if more time is needed to demonstrate adequate progress.   A No Cost Time Extension of the project is also possible by written request. Please note that a late submission, even if funded, could result in a temporary lapse in funding.


No Cost Time Extension

To obtain a no cost time extension, a letter of request should be submitted to the BMRP by the Principal Investigator prior to the end of the grant period.  Ideally, we request that the letter be given to us 1 month prior to the Grant Award's end date.  The letter can be submitted electronically and should include the following information:

  • The anticipated balance remaining at the end of the currently funded period; 
  • The number of additional months needed; and 
  • A justification for the extension.

Final Reports and Publications

1.    A Final Technical Progress Report is due to the BMRP 3 months after the end of the grant period. The Final Technical Progress Report should be submitted electronically and include the following: 

     (a)    Summary of project aims;

     (b)    Accomplishments toward meeting those aims;

     (c)    A list of significant results (positive or negative);

     (d)    A list of publications resulting from the grant. Send all pre-prints of manuscripts electronically as soon as they are accepted for publication and all reprints of the final published articles that have not previously been sent to the BMRP. All publications resulting in whole or in part from this grant are to acknowledge receipt of funding from the Broad Medical Research Program at CCFA.

     (e)    Disclosure and description of any patents received or pending that have resulted in whole or in part from the BMRP supported project;

     (f)    A list of applications submitted to other granting agencies to continue work on this project, including the outcome of those proposals.

             Provide the following information:

             1)    Name of the funding agency.

             2)    Funding status (e.g., pending, received or not funded).

             3)    Type of grant requested (e.g., research grant, fellowship, career award).

             4)    Total amount requested (in U.S. dollars).

             5)    If funded by another agency, please also include:

                     i)    Total amount awarded (direct plus indirect) for the entire project period

                     ii)    Number of years of support received

                     iii)    Year in which funding began. If no applications have been submitted, please indicate why and describe plans for requesting continued funding of this project from other agencies.

     (g)    Lay summary of the progress report (not to exceed one page), written in non-scientific terms.

The BMRP will continue to follow up with Principal Investigators for several years after the conclusion of funding. This is extremely important in order to document the BMRP’s success in funding the research. Principal Investigators should e-mail to us all reprints of publications resulting in whole or in part from BMRP grants, disclose resulting patents and inform us of any grants received from other sources for their BMRP-supported project.

2.    A signed Final Financial Report is to be submitted by the institutional accounting office within 3 months after the end of the grant period and must contain the expenditures for the entire period of the grant. The BMRP will provide the financial report form on Proposal Central for the grantee institution to complete. If there are more than $500 U.S. in grant funds remaining that are not expended or committed within the grant period (or authorized extension thereof), these are to be returned to the BMRP along with the final financial report. If the remaining balance is $500 U.S. or less, it is to be retained by the grantee institution for use by the Principal Investigator in support of his/her research.


Last updated 05/03/2016